CME Information and Learning Objectives Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the sponsorship of the American College of Mohs Surgery (ACMS). The ACMS is accredited by the ACCME to provide continuing medical education for physicians. Credit Designation Statement The ACMS designates this live activity for a maximum of 38.50 AMA PRA Category 1 Credit(s) TM . Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physician Assistant Credit The American Academy of Physician Assistants (AAPA) accepts AMA PRA Category 1 Credit(s) TM from organizations accredited by the ACCME. Physician Assistants attending the Annual Meeting can submit certificates or transcripts showing how many physician CME credits were offered for an activity to the AAPA and get them “converted” to PA CME credit. The AAPA also grants and counts AMA PRA Category 1 Credit(s) TM , but those are specifically for PAs and have to come from a provider accredited by the AAPA. Both groups label their credits Category 1 CME, but the labels, though they read the same, refer to different evaluations. Disclosure of Conflicts of Interest To comply with the ACCME Standards of Commercial Support on the need for disclosure and monitoring of proprietary and financial interests that may affect the scientific integrity and balance of content delivered in continuing medical education activities under our auspices. The ACMS requires that all CME certified activities be developed free from the control of a commercial interest and be balanced, objective, and scientifically rigorous. Anyone with the ability to affect the content of an educational activity must disclose relevant financial relationships with commercial interests producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACMS will disclose faculty and commercial relationships at the Annual Meeting. Disclosure of Discussion of Non-FDA Approved Uses for Pharmaceutical Products and/or Medical Devices The ACMS requires that all faculty presenters identify and disclose any off-label uses for pharmaceutical and medical device products. The ACMS recommends that each physician fully review all the available data on new products or procedures prior to instituting them with patients.
Disclaimer The views expressed and the techniques presented by the speakers of the ACMS-sponsored educational meetings are not necessarily shared or endorsed by the College. Anyone with the ability to affect the content of an educational activity must disclose relevant financial relationships with commercial interests producing, marketing, reselling, or distributing health care goods or services consumed by, or used on, patients, as well as any unapproved or off-label uses of medical devices or pharmaceutical agents that they discuss, describe, or demonstrate during their presentations. Meeting attendees should use their independent judgment in applying the information discussed in these educational sessions in the treatment of patients. Learning Objectives Upon completion of the Annual Meeting, participants will be able to describe the latest advances in the treatment of skin cancer, discuss recent research findings in the area of Mohs micrographic surgery and cutaneous oncology, and explain new techniques in reconstruction that promote optimal surgical outcomes. Specific learning objectives, upon completion of the ACMS Annual Meeting, include: • Design and execute Mohs stages and routine and advanced reconstructions of the face, hands, nails, feet and genitalia; • Describe current recommendations for diagnosis and treatment of melanoma, and Merkel cell cancer; • Recall the benefits and techniques involved in utilizing immunohistochemistry in the treatment of melanoma and non- melanoma skin cancers as well as the indications and limitations of the same; • Refine reconstruction techniques to improve scars post Mohs micrographic surgery; • Identify anatomic landmarks and integrate knowledge of those landmarks into the practice of Mohs micrographic surgery; • Recognize potential errors in frozen section examination of skin cancers and develop ways to minimize those errors; • Explain proper billing and coding practices for Mohs and reconstructive surgery; • Recognize indications for multidisciplinary collaboration with medical and surgical colleagues; • Identify elements of the preoperative history that require management preoperatively; • Review the most recent literature regarding dermatologic surgery and cutaneous oncology; • Describe recent developments in the management of skin cancer in organ transplant recipients and other immunosuppressed populations; • Recall staging for cutaneous cancers including SCC, Melanoma, and Merkel cell carcinoma.
8
2021 ACMS Annual Meetings Hyatt Regency Seattle, Seattle, WA • Thursday, May 6 – Sunday, May 9, 2021
Made with FlippingBook HTML5